Page 57 - ARNM-1-1

Advances in Radiotherapy &

Nuclear Medicine

CASE REPORT
A case report of refractory pulmonary

adenocarcinoma

Haiyan Li, Chifeng Xu, and Xia Lu*
Department of Nuclear Medicine, Northern Jiangsu People’s Hospital, Yangzhou, China

Abstract

As one of the most common types of carcinomas, lung cancer has high incidence
and mortality rates. Among the pathological types of lung cancer, pulmonary
adenocarcinoma is the most prevalent. Advancements in medical treatments have
contributed to improved prognosis in pulmonary adenocarcinomas. However,
this case report revealed a rare refractory lung adenocarcinoma, suggesting that
further research and robust management strategies are needed to improve clinical
outcomes. In this regard, F-fluorodeoxyglucose positron emission tomography/
18
computed tomography plays a very important role in the comprehensive evaluation
of glucose metabolic activity in lung adenocarcinoma and the progression of
metastasis in distant organs.

Keywords: Pulmonary adenocarcinoma; F-fluorodeoxyglucose positron emission
18
tomography/computed tomography; Treatment; Prognosis

*Corresponding author: 1. Background
Xia Lu
(lxgf2222@163.com) Pathological subtypes and clinical staging of lung adenocarcinoma affect patient
treatment and prognosis directly. Good outcomes come from a systematic, standardized,
Citation: Li H, Xu C, Lu X, 2023,
A case report of refractory and scientific treatment plan based on tumor type and precise clinical staging. This
pulmonary adenocarcinoma. Adv case is a rare refractory papillary adenocarcinoma, presented with a small pulmonary
Radiother Nucl Med. primary lesion but early extensive metastases and poor outcomes after robust systematic
https://doi.org/10.36922/arnm.0883
treatment medical treatment.
Received: April 29, 2023
Accepted: June 16, 2023 2. Case presentation
Published Online: June 28, 2023 A 53-year-old man, with pain in the right shoulder joint as well as limited movement
for 2 months and a family history of gastrointestinal malignant tumors, was admitted
Copyright: © 2023 Author(s).
This is an Open-Access article to the hospital for further diagnosis and treatment. The bone scan (Figure 1A) showed
distributed under the terms of the increased radioactivity at the proximal end of the right humerus, the left sixth rib, and
Creative Commons Attribution the first lumbar vertebra that diagnosed metastatic lesions. Computed tomography
License, permitting distribution,
and reproduction in any medium, (CT) scanning of the right shoulder joint (Figure 1B and C) presented destruction of
provided the original work is the right humerus with surrounding soft-tissue masses. CT plain examination of the
properly cited. chest (Figure 1E and F) detected a nodule in the lower lobe near the pleura of the left
Publisher’s Note: AccScience lung and sized 24 mm × 18 mm, which has small bubbles inside. Pathological findings
Publishing remains neutral with validated the metastatic lesions of the humerus (Figure 1D) were poorly differentiated
regard to jurisdictional claims in
published maps and institutional adenocarcinoma of non-small cell lung cancer (NSCLC) from the lower lobe of the
affiliations. left lung (Figure 1G). F-fluorodeoxyglucose positron emission tomography/CT
18

Volume 1 Issue 1 (2023) 1 https://doi.org/10.36922/arnm.0883